Outcomes of living-related liver transplantation for Wilson's disease: A single-center experience in China

Transplantation

Volumn 87, Issue 5, 2009, Pages 751-757

  Cheng, Feng ^a,b   Li, Guo Qiang ^a,b   Zhang, Feng ^a,b   Li, Xiang Cheng ^a,b   Sun, Bei Cheng ^a,b   Kong, Lian Bao ^a,b   Pu, Li Yong ^a,b   Wang, Ke ^a,b   Qian, Xiao Feng ^a,b   You, Wei ^a,b   Wang, Xue Hao ^a,b  

^a BEIJING HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Living related liver transplantation; Neurologic; Orthotopic liver transplantation; Wilson's disease

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CHINA; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; LIVER FAILURE; LIVER GRAFT; LIVING DONOR; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT INDICATION; TREATMENT OUTCOME; WILSON DISEASE; ADULT; BLOOD; LIVER RESECTION; LIVER TRANSPLANTATION; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; PHYSIOLOGY; SURVIVAL; SURVIVOR;

CERULOPLASMIN; COPPER;

ADOLESCENT; ADULT; CERULOPLASMIN; CHILD; CHINA; COPPER; FEMALE; HEPATECTOMY; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS; TREATMENT OUTCOME;

EID: 65649085214     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318198a46e     Document Type: Article

References (28)

1. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003; 23: 139.
2. Roberts EA, Schilsky M. A practice guideline on Wilson disease. Hepatology 2003; 37: 1475.
3. Medici V, Mirante VG, Fassati LR, et al. Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders. Liver Transpl 2005; 11: 1056.
4. Sutcliffe RP, Maguire DD, Muiesan P, et al. Liver transplantation for Wilson's disease: Long-term results and quality-of-life assessment. Transplantation 2003; 75: 1003.
5. Eghtesad B, Nezakatgoo N, Geraci LC, et al. Liver transplantation for Wilson's disease: A single-center experience. Liver Transpl Surg 1999; 5:467.
6. Emre S, Atillasoy EO, Ozdemir S, et al. Orthotopic liver transplantation for Wilson's disease: A single-center experience. Transplantation 2001; 72:1232.
7. Tamura S, Sugawara Y, Kishi Y, et al. Living-related liver transplantation for Wilson's disease. Clin Transplant 2005; 19: 483.
8. Suzuki s, Sato Y, Ichida T, et al. Recovery of severe neurologic manifestations of Wilson's disease after living-related liver transplantation: A case of report. Transplant Proc 2003; 35: 385.
9. Wang XH, Cheng F, Zhang F, et al. Living-related liver transplantation for Wilson's disease. Transpl Int 2005; 18: 651.
10. Weisner R, Edwards E, Freeman R, et al. Model for end-stage liver disease and allocation of donor livers. Gastroenterology 2003; 124: 91.
11. Dubois RS, Giles G, Rodgerson DO, et al. Orthtopic liver transplantation for Wilson's disease. Lancet 1971; 1: 505.
12. Komatsu H, Fujisawa T, Inui A, et al. Hepatic copper concentration in children undergoing living related liver transplantation due to Wilsonian fulminant hepatic failure. Clin Transplant 2002; 16: 227.
13. Asonuma K, Inomata Y, Kasahara M, et al. Living related liver transplantation from heterozygote genetic carriers to children with Wilson's disease. Pediatr Transplant 1999; 3: 201.
14. El-Karaksy H, Nomachi S, Esmat G, et al. Equal outcome of living-related liver transplantation for Wilson's disease from heterozygote and nonheterozygote donors: A report of a brother and sister. Indian J Med Sci 2007; 61: 286.
15. Sokal RJ, Francis PD, Gold SH, et al. Orthtopic liver transplantation for acute fulminant Wilson's disease. J pediatr 1985; 107: 549.
16. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464.
17. Freeman RB Jr, Edwards EB. Liver transplant waiting time does not correlate with waiting list mortality: Implications for liver allocation policy. Liver Transpl 2000; 6: 543.
18. Baliga P, Merion RM, Turcotte JG, et al. Preoperative risk factor assessment in liver transplantation. Surgery 1992; 112: 704.
19. Eghtesad B, Bronsther O, Irish W, et al. Disease gravity and urgency of need as guidelines for liver allocation. Hepatology 1994; 20: 56S.
20. Polson RJ, Rolles K, Calne RY, et al. Reversal of severe neurological manifestations of Wilson's disease following orthtopic liver transplantation. Q J Med 1987; 64: 685.
21. Schilsky ML, Scheinberg IH, Sternlieb I, et al. Liver transplantation for Wilson's disease: Indications and outcomes. Hepatology 1994; 19: 583.
22. Bax RT, Hassler A, Luck W, et al. Cerebral manifestation of Wilson's disease successfully treated with liver transplantation. Neurology 1998; 51: 863.
23. Geissler I, Heinemann S, Rohm J, et al. Liver transplantation for hepatic and neurological Wilson's disease. Transplant Proc 2003; 35: 1445.
24. Mason AL, Marsh W, Alpers DH. Intractable neurological Wilson's disease treated with orthotopic liver transplantation. Dig Dis Sci 1993; 38: 1746.
25. Caca K, Ferenci P, Kuhn HJ, et al. High prevalence of the H1069Q mutation in East German patients with Wilson disease: Rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol 2001; 35: 575.
26. Kim Ek, Yoo QJ, Song KY, et al. Identification of three novel mutations and high frequency of the Arg778Leu mutations in Korean patients with Wilson disease. Hum Mutat 1998; 11: 275.
27. Nanji MS, Nguyen VT, Kawasoe JH, et al. Haplotype and mutation analysis in Japanese patients with Wilson disease. Am J Hum Genet 1997; 60: 1423.
28. Wu ZY, Wang N, Lin MT, et al. Mutation analysis and the correlation between genotype and phenotype of Arg778Leu mutation in Chinese patients with Wilson disease. Arch Neurol 2001; 58: 971.